Evidence map›Paper›PMID 32363077›Full record

ArticleACS catalysis2020

Dynamics of a Key Conformational Transition in the Mechanism of Peroxiredoxin Sulfinylation.

Alexandre Kriznik, Marouane Libiad, Hélène Le Cordier, Samia Boukhenouna, Michel B Toledano, Sophie Rahuel-Clermont

Open access · bronzeAbstract read
In one paragraph

Article in ACS catalysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alexandre KriznikIMoPA, Université de Lorraine, CNRS, Biopole, Campus Biologie Sante', F-54000 Nancy, France.
Marouane LibiadLaboratoire Stress oxydant et Cancer, Institute for Integrative Biology of the Cell (I2BC), UMR9198, CNRS, CEA-Saclay, Université Paris-Saclay, iBiTecS/SBIGEM, Bat 142, F-91198 Gif-sur-Yvette Cedex, France.
Hélène Le CordierIMoPA, Université de Lorraine, CNRS, Biopole, Campus Biologie Sante', F-54000 Nancy, France.
Samia BoukhenounaIMoPA, Université de Lorraine, CNRS, Biopole, Campus Biologie Sante', F-54000 Nancy, France.
Michel B ToledanoLaboratoire Stress oxydant et Cancer, Institute for Integrative Biology of the Cell (I2BC), UMR9198, CNRS, CEA-Saclay, Université Paris-Saclay, iBiTecS/SBIGEM, Bat 142, F-91198 Gif-sur-Yvette Cedex, France.
Sophie Rahuel-ClermontIMoPA, Université de Lorraine, CNRS, Biopole, Campus Biologie Sante', F-54000 Nancy, France.
Centre National de la Recherche Scientifique · FRIngénierie Moléculaire et Physiopathologie Articulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxiredoxins from the Prx1 subfamily (Prx) are moonlighting peroxidases that operate in peroxide signaling and are regulated by sulfinylation. Prxs offer a major model of protein-thiol oxidative modification. They react with H

Identifiers

PMID32363077
PMCPMC7189429
OpenAlexW3003564704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.